ECOR - electroCore, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
8.14
-0.13 (-1.57%)
As of 12:43PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close 8.27
Open 8.26
Bid 8.11 x 1800
Ask 8.12 x 1100
Day's Range 7.72 - 8.40
52 Week Range 4.16 - 20.25
Volume 52,362
Avg. Volume 144,660
Market Cap 239.723M
Beta (3Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) N/A
Earnings Date N/A
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A
Trade prices are not sourced from all markets
  • 4 Stocks Join Ben Graham Net-Net Screener Friday
    GuruFocus.com 11 days ago

    4 Stocks Join Ben Graham Net-Net Screener Friday

    While many investors are enjoying a lift in their stocks, the Ben Graham Screener, which finds net-nets, has been active

  • Is electroCore, Inc.’s (NASDAQ:ECOR) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St. 3 months ago

    Is electroCore, Inc.’s (NASDAQ:ECOR) Balance Sheet Strong Enough To Weather A Storm?

    The direct benefit for electroCore, Inc. (NASDAQ:ECOR), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. However, the trade-off is Read More...

  • Who Really Owns electroCore Inc (NASDAQ:ECOR)?
    Simply Wall St. 6 months ago

    Who Really Owns electroCore Inc (NASDAQ:ECOR)?

    If you want to know who really controls electroCore Inc (NASDAQ:ECOR), then you’ll have to look at the makeup of its share registry. Institutions will often hold stock in biggerRead More...

  • 8 Biotech Stocks With IPOs This Week
    InvestorPlace 9 months ago

    8 Biotech Stocks With IPOs This Week

    This week, there are a whopping eight biotech companies going public. Biotechnology isn’t an easy sector to grasp — it takes dedication to understand investment thesis, beginning the journey from drug development and ending at the drugstore. When it comes to investing in biotech stocks, the question is not just how well is this business run but whether their products fulfill a need in a growing industry … for biotechs, this can get complicated.

  • Benzinga 9 months ago

    The IPO Outlook For The Week Of June 18: Pharma, Pharma And More Pharma

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . Eidos Therapeutics, Inc. (NASDAQ: EIDX ) will issue 6.25 million shares between $15 and $17 Wednesday on the Nasdaq. The ...